These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 630641)

  • 1. Some antitumor derivatives of ellipticine deprived of mutagenic properties.
    Lecointe P; Lesca P; Cros S; Paoletti C
    Chem Biol Interact; 1978 Jan; 20(1):113-21. PubMed ID: 630641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ellipticines and human liver microsomes: spectral interaction with cytochrome P-450 and hydroxylation. Inhibition of aryl hydrocarbon metabolism and mutagenicity.
    Lesca P; Beaune P; Monsarrat B
    Chem Biol Interact; 1981 Sep; 36(3):299-309. PubMed ID: 7285236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.
    DeMarini DM; Cros S; Paoletti C; Lecointe P; Hsie AW
    Cancer Res; 1983 Aug; 43(8):3544-52. PubMed ID: 6344986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ellipticines as potent inhibitors of microsomes-dependent chemical mutagenesis.
    Lesca P; Lecointe P; Paoletti C; Mansuy D
    Chem Biol Interact; 1979 May; 25(2-3):279-87. PubMed ID: 380828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and pharmacological properties of the antitumor ellipticine derivative 2-(diethylamino-2-ethyl)9-hydroxy ellipticinium-chloride, HCl.
    Auclair C; Pierre A; Voisin E; Pepin O; Cros S; Colas C; Saucier JM; Verschuere B; Gros P; Paoletti C
    Cancer Res; 1987 Dec; 47(23):6254-61. PubMed ID: 3677074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia.
    Paoletti C; Cros S; Xuong ND; Lecointe P; Moisand A
    Chem Biol Interact; 1979 Apr; 25(1):45-58. PubMed ID: 466727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ellipticines as potent inhibitors of aryl hydrocarbon hydroxylase: their binding to microsomal cytochromes P450 and protective effect against benzo(a)pyrene mutagenicity.
    Lesca P; Lecointe P; Paoletti C; Mansuy D
    Biochem Pharmacol; 1978; 27(8):1203-9. PubMed ID: 697921
    [No Abstract]   [Full Text] [Related]  

  • 8. Ellipticine, 9-hydroxyellipticine, and 9-hydroxyellipiticinum: some biochemical properties of possible pharmacologic significance.
    Paoletti C; Auclair C; Lesca P; Tocanne JF; Malvy C; Pinto M
    Cancer Treat Rep; 1981; 65 Suppl 3():107-18. PubMed ID: 7049365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial and nuclear mutagenicity of ellipticine and derivatives in the yeast Saccharomyces cerevisiae.
    Pinto M; Guerineau M; Paoletti C
    Biochem Pharmacol; 1982 Jun; 31(12):2161-7. PubMed ID: 7052092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2 new antineoplastic derivatives: 9-hydroxy-2-methyl-ellipticinium (acetate) and 9-hydroxy-2,6-dimethyl-ellipticinium (chloride). Effect on mouse L 1210 leukemia].
    Le Pecq JB; Gosse C; Nguyen-Dat-Xuong ; Paoletti C
    C R Acad Hebd Seances Acad Sci D; 1975 Nov; 281(18):1365-7. PubMed ID: 815025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of 4-S proteins from rat and mouse liver. High affinity of ellipticines.
    Roy M; Fernandez N; Lesca P
    Eur J Biochem; 1988 Mar; 172(3):593-9. PubMed ID: 2832169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium.
    Zwelling LA; Michaels S; Kerrigan D; Pommier Y; Kohn KW
    Biochem Pharmacol; 1982 Oct; 31(20):3261-7. PubMed ID: 7150355
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-activity relationships in the inhibitory effects of ellipticines on benzo(a)pyrene hydroxylase activity and 3-methylcholanthrene mutagenicity.
    Lesca P; Lecointe P; Pelaprat D; Paoletti C; Mansuy D
    Biochem Pharmacol; 1980 Dec; 29(24):3231-7. PubMed ID: 7213401
    [No Abstract]   [Full Text] [Related]  

  • 14. Ellipticine derivatives with an affinity to the estrogen receptor, an approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer.
    Delbarre A; Oberlin R; Roques BP; Borgna JL; Rochefort H; Le Pecq JB; Jacquemin-Sablon A
    J Med Chem; 1985 Jun; 28(6):752-61. PubMed ID: 4009597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic effects of the lysosomotropic agents DNA-ellipticine, DNA-daunorubicin, and DNA-ellipticine:daunorubicin on L1210 leukemia cells.
    Sorace RA; Sheid B
    Cancer Treat Rep; 1979 Jan; 63(1):43-51. PubMed ID: 421232
    [No Abstract]   [Full Text] [Related]  

  • 16. omicron-Quinone formation in the biochemical oxidation of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate.
    Bernadou J; Meunier G; Paoletti C; Meunier B
    J Med Chem; 1983 Apr; 26(4):574-9. PubMed ID: 6834391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Syntheses designed to produce 8-amino ellipticine. Synthesis and pharmacological properties of 8-nitro ellipticine].
    Gansser C; Lévque X; Plat M; Viel C
    Farmaco Sci; 1982 May; 37(5):283-97. PubMed ID: 7095141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro.
    Paoletti C; Lesca C; Cros S; Malvy C; Auclair C
    Biochem Pharmacol; 1979; 28(3):345-50. PubMed ID: 426849
    [No Abstract]   [Full Text] [Related]  

  • 19. Dissolution and absorption of the antineoplastic agent ellipticine.
    Rahman A; Cradock JC; Davignon JP
    J Pharm Sci; 1978 May; 67(5):611-4. PubMed ID: 641792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage and cytotoxicity in L1210 cells by ellipticine and a structural analogue, N-2-(diethylaminoethyl)-9-hydroxyellipticinium chloride.
    Djuric Z; Everett CK; Valeriote FA
    Cancer Res; 1992 Mar; 52(6):1515-9. PubMed ID: 1540960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.